plerixafor has been researched along with Acute Brain Injuries in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jin, G; Mao, W; Qin, J; Tian, M; Yi, X | 1 |
| Ji, Y; Li, Y; Liu, X; Wang, X; Xu, G; Yan, J; Zhou, C | 1 |
2 other study(ies) available for plerixafor and Acute Brain Injuries
| Article | Year |
|---|---|
CXCL12 inhibits cortical neuron apoptosis by increasing the ratio of Bcl-2/Bax after traumatic brain injury.
Topics: Animals; Apoptosis; bcl-2-Associated X Protein; Benzylamines; Brain Injuries; Caspase 3; Cerebral Cortex; Chemokine CXCL12; Cyclams; Heterocyclic Compounds; Male; Neurons; Neuroprotective Agents; Proto-Oncogene Proteins c-bcl-2; Rats; Receptors, CXCR4; Up-Regulation | 2014 |
SDF-1 promotes endochondral bone repair during fracture healing at the traumatic brain injury condition.
Topics: Animals; Antibodies, Neutralizing; Benzylamines; Brain Injuries; Cell Movement; Cells, Cultured; Chemokine CXCL12; Chemotaxis; Cyclams; Femur; Fracture Healing; Gene Expression; Heterocyclic Compounds; Immunohistochemistry; Mesenchymal Stem Cells; Mice; Mice, Inbred C57BL; Receptors, CXCR4; Recombinant Proteins; Reverse Transcriptase Polymerase Chain Reaction; Time Factors | 2013 |